10.1.1 At the end of 2023, the Alliance for Regenerative Medicine (ARM) reported (from GlobalData) 2,120 clinical trials for advanced therapies underway around the world — a decrease of 4% from 2,220 trials in 2022. The global distribution of clinical trials around the world retained a similar pattern as in 2023, with 45% in North America, 35% in Asia–Pacific, and 20% in Europe (Figure 14). The trials are being sponsored by 2,526 cell and gene therapy developers.[50]
Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.